OSU Comprehensive Cancer Center

Columbus, Ohio 43210

1 studies enrolling now · 3 studies all time

What they study most

CLL, CLL (Chronic Lymphocytic Leukemia), CLL / SLL, CLL Progression, CLL, Refractory, CLL, Relapsed, Gastrointestinal Stromal Tumors, Melanoma, Metastatic Melanoma, SLL, SLL (Small Lymphocytic Lymphoma)

Studies at this site

• ROCKET-CLL Global Phase 3 Study: Rocbrutinib vs Pirtobrutinib in cBTKi-Pretreated R/R CLL/SLL — Recruiting now
• CGT9486 (Formerly Known as PLX9486) as a Single Agent and in Combination With PLX3397 (Pexidartinib) or Sunitinib in Participants With Advanced Solid Tumors — Completed
• Trial of Vemurafenib/Cobimetinib With or Without Bevacizumab in Patients With Stage IV BRAFV600 Mutant Melanoma — Stopped early